CN100358552C - Medicine for treating amblyopia and its preparing method - Google Patents
Medicine for treating amblyopia and its preparing method Download PDFInfo
- Publication number
- CN100358552C CN100358552C CNB2005100166582A CN200510016658A CN100358552C CN 100358552 C CN100358552 C CN 100358552C CN B2005100166582 A CNB2005100166582 A CN B2005100166582A CN 200510016658 A CN200510016658 A CN 200510016658A CN 100358552 C CN100358552 C CN 100358552C
- Authority
- CN
- China
- Prior art keywords
- medicine
- rhizoma
- amblyopia
- treatment
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The present invention discloses a medicine for treating amblyopia and a preparation method thereof, which has the main technical scheme that the medicine is prepared from American ginseng, hemlock parsley, leonurus, barbary wolfberry fruit, bupleurum root, hawthorn fruit, largehead atractylodes rhizome, largetrifoliolious bugbane rhizome and turtle shell as raw materials, wherein impurities in the raw materials are removed, and then the raw materials are cleaned, dried and pulverized into 120 meshes of fine powder. Thus, the medicine powder is prepared. If a proper amount of honey is added to the medicine powder, honeyed pills can be prepared. The medicine powder can be directly filled into capsules. The medicine has an obvious treatment effect of treating amblyopia.
Description
Technical field:
The present invention relates to a kind of medicine for the treatment of ophthalmic diseases, more particularly, is particularly children's myopia using of treatment amblyopia, and it is to be the Chinese patent medicine of feedstock production with pure Chinese medicine, and the present invention also reaches the preparation method that relates to its this medicine.
Background technology:
Amblyopia is a kind of common ophthalmic diseases, sickness rate is high, serious harm people are child's physical and mental health particularly, treats primary disease at present and still finds no good method, generally all adopts physiotherapy, as: magnetic therapy, black material hide, rub in the acupuncture point touches etc., though these therapies play certain therapeutical effect, can not eradicate, easily return bullet, and treatment time is long, and efficacy result is undesirable.
Summary of the invention:
The objective of the invention is to overcome the existing deficiency that the treatment amblyopia is particularly existed in the children's myopia using, a kind of medicine for the treatment of amblyopia is provided.
Another goal of the invention of the present invention provides the preparation method of the medicine of treatment amblyopia.
Solution of the present invention be based on Chinese medicine to ophthalmic diseases particularly to pathogenetic understanding of amblyopia and Therapeutic Principle, with reference to modern pharmacology, from Chinese medicine, filter out replenishing vital essence to improve eyesight, halo vision ear toot, natural animal-plant medicine such as the body resistance strengthening and constitution consolidating, blood-activating and qi-promoting, soothing liver-QI yang invigorating, by theory of Chinese medical science, monarch, minister, the combination principle of helping, making, carry out scientific composition, reach the purpose of treatment amblyopia.
Medicine of the present invention is made by following set of dispense, (consumption is a weight portion)
Radix Panacis Quinquefolii 10-20 Rhizoma Chuanxiong 10-20 Herba Leonuri 15-30 Fructus Lycii 25-30
Radix Bupleuri 10-20 Fructus Crataegi 20-40 Rhizoma Atractylodis Macrocephalae 20-25 Rhizoma Cimicifugae 15-30
Carapax Trionycis 20-30
Preparing medicine optimum amount weight of the present invention (part) proportioning is:
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20
The Rhizoma Atractylodis Macrocephalae 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20
The preparation method of medicine of the present invention is:
By its said medicine weight (part) proportioning, get crude drug, Radix Panacis Quinquefolii, Rhizoma Chuanxiong, Herba Leonuri, Fructus Lycii, Radix Bupleuri, Fructus Crataegi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Cimicifugae, Carapax Trionycis are removed impurity, cleaning, drying, crushing screening to 120 order fine powder, drug powder of the present invention.Drug powder of the present invention adds proper honey, can be made into honeyed pill, also can directly pour into capsule.
Radix Panacis Quinquefolii has effects such as strongly invigorating primordial QI, multiple arteries and veins take off admittedly, promoting the production of body fluid and inducing sedation of the mind in the medicine of the present invention; Rhizoma Chuanxiong has the effect of blood-activating and qi-promoting, wind-expelling pain-stopping; Herba Leonuri can be invigorated blood circulation, inducing diuresis to remove edema; Fructus Lycii energy nourishing the liver and kidney, replenishing vital essence to improve eyesight; Radix Bupleuri has the soothing liver-QI yang invigorating, evacuates the effect of bringing down a fever; Fructus Crataegi energy promoting digestion and invigorating the stomach, the circulation of qi promoting dissipating blood stasis; The Rhizoma Atractylodis Macrocephalae has invigorating the spleen and benefiting QI, the effect of dampness diuretic; Rhizoma Cimicifugae has the effect of the rash of delivering, heat-clearing and toxic substances removing, and Carapax Trionycis has nourishing YIN for suppressing the hyperactive YANG, hard masses softening and resolving, brings down a fever to remove and steam.The present invention gives full play to the function of each drug effect, makes it reach the purpose of treatment amblyopia.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, selecting natural plant for use is raw material, does not add any additives, therefore, nontoxic to human body, have no side effect;
2, medicine of the present invention does not need special processing, makes the natural components of medicine not be damaged taking convenience;
3, wide accommodation is as all having significant curative effect and do not return bullet refractive amblyopia, congenital amblyopia, pseudomyopia, true and false mixed type myopia etc.;
Instructions of taking: if take powder child 5 gram/time, adult's 10 grams/time, day clothes 2 times, boiled water is taken after mixing it with water after meal.It is the same with taking powder to take pill or capsule dose, method.20 days is a course of treatment, and general patient can take effect a course of treatment, and can cure three courses of treatment.
The specific embodiment:
Press following proportioning weighting raw materials (kilogram):
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20 Rhizoma Atractylodis Macrocephalaes 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20
Production method is as follows:
With said medicine, remove impurity, cleaning, drying are pulverized, and are screened to 120 order fine powders, mix drug powder of the present invention.Drug powder of the present invention adds proper honey, can be made into honeyed pill, also can directly pour into capsule.
Claims (3)
1, a kind of medicine for the treatment of amblyopia is characterized in that it is the medicament of being made by the following weight proportion raw material:
Radix Panacis Quinquefolii 10-20 Rhizoma Chuanxiong 10-20 Herba Leonuri 15-30 Fructus Lycii 25-30
Radix Bupleuri 10-20 Fructus Crataegi 20-40 Rhizoma Atractylodis Macrocephalae 20-25 Rhizoma Cimicifugae 15-30
Carapax Trionycis 20-30.
2, a kind of medicine for the treatment of amblyopia according to claim 1 is characterized in that each crude drug weight proportion is:
Radix Panacis Quinquefolii 15 Rhizoma Chuanxiongs 10 Herba Leonuris 15 Fructus Lycii 15 Radix Bupleuri 25 Fructus Crataegis 20
The Rhizoma Atractylodis Macrocephalae 20 Rhizoma Cimicifugaes 15 Carapax Trionycis 20.
3, a kind of preparation method for the treatment of the medicine of amblyopia according to claim 2, it is characterized in that: get crude drug Radix Panacis Quinquefolii, Rhizoma Chuanxiong, Herba Leonuri, Fructus Lycii, Radix Bupleuri, Fructus Crataegi, the Rhizoma Atractylodis Macrocephalae, Rhizoma Cimicifugae, Carapax Trionycis, remove impurity, clean, dry, be crushed to 120 order fine powders, make powder after fully mixing; Mixed fine powder pours into capsule or add proper honey in mixed fine powder makes honeyed pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100166582A CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100166582A CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1836705A CN1836705A (en) | 2006-09-27 |
| CN100358552C true CN100358552C (en) | 2008-01-02 |
Family
ID=37014299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100166582A Active CN100358552C (en) | 2005-03-24 | 2005-03-24 | Medicine for treating amblyopia and its preparing method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100358552C (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105213620A (en) * | 2015-09-11 | 2016-01-06 | 胡庆丰 | A kind of medicine for the treatment of ophthalmic diseases |
| CN105168575A (en) * | 2015-09-11 | 2015-12-23 | 胡庆丰 | Medicine for treating amblyopia ophthalmic diseases of children |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1178682A (en) * | 1996-10-07 | 1998-04-15 | 郭书文 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
| CN1220161A (en) * | 1998-11-17 | 1999-06-23 | 梅唤群 | Specific drug for curing myopia |
-
2005
- 2005-03-24 CN CNB2005100166582A patent/CN100358552C/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1149481A (en) * | 1996-04-16 | 1997-05-14 | 郭良才 | Capsule for enhancing eyesight |
| CN1178682A (en) * | 1996-10-07 | 1998-04-15 | 郭书文 | Chinese drug Mingmudan pill for improving eyesight and its producing method |
| CN1220161A (en) * | 1998-11-17 | 1999-06-23 | 梅唤群 | Specific drug for curing myopia |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1836705A (en) | 2006-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102133378B (en) | Medicament for treating breast cancer | |
| CN103656238B (en) | A kind of Chinese medicine composition for the treatment of rheumatic osteopathia | |
| CN101019975A (en) | Fracture treating Chinese medicine composition and its prepn | |
| CN100998838A (en) | Chinese medicine for relaxing muscles and tendons to promote blood circulation preparation method thereof | |
| CN102106923A (en) | Chinese medicinal preparation for treating osteoporosis | |
| CN100368001C (en) | Medicine composition for treating rheumatic arthritis and rheumatoid arthritis, and its prepn. method | |
| CN101647947A (en) | Mongolian medicinal preparation for treating eye diseases | |
| CN103735790A (en) | Traditional Chinese medicine composition for treating tinnitus | |
| CN103316192A (en) | Traditional Chinese medicine foot-bathing liquid for treating lumbocrural pain and preparation method thereof | |
| CN104524159A (en) | Pharmaceutical composition for treating hyperplasia of mammary glands | |
| CN100352465C (en) | Medicinal liquor for treating rheumatic arthrolithiasis and its preparing method | |
| CN100409870C (en) | Chinese traditional medicinal composition for treating psoriasis | |
| CN100358552C (en) | Medicine for treating amblyopia and its preparing method | |
| CN106390077A (en) | Pharmaceutical composition for treating stomachache and diarrhea and preparation method and application thereof | |
| CN100450520C (en) | Medicine for treating chronic glomerular nephritis and its producing method | |
| CN102552708A (en) | Medicinal composition for calming liver wind | |
| CN105833179A (en) | Traditional Chinese medicine for treating nonalcoholic steatohepatitis | |
| CN1053189A (en) | The preparation method of " promoting blood circulation and restoring paralysis pills " | |
| CN105250427A (en) | Pharmaceutical composition for treating heart diseases | |
| CN102657839B (en) | Traditional Chinese medicine capsule for treating coronary heart disease | |
| CN101703710A (en) | Chinese medicinal preparation for treating gout | |
| CN103417876A (en) | Digestion and detoxification pill and preparing method thereof | |
| CN102961575A (en) | Formula of traditional Chinese medicine for treating viral cardiac neurosis | |
| CN102000286A (en) | Traditional Chinese medicine preparation for treating polyneuritis | |
| CN106266204A (en) | One treats osteoporotic medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |